RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing

Completed · Not applicable

Conditions studied: Opioid-Related Disorders, Opioid-use Disorder, Drug Addiction, Substance Use Disorders

In brief

The purpose of this research study is to: 1. assess how well individuals entering medication assisted treatment like the RETAIN e-health application as measured by their feedback on the intervention. 2. test the impact of RETAIN on knowledge about medication-assisted treatment(MAT). 3. assess treatment retention rates in patients completing the RETAIN intervention. 4. test the impact of RETAIN on knowledge about HCV/HIV 5. test the impact of RETAIN on interest in being tested for HCV/HIV

Key facts

Study ID

NCT03411265

Run by

University of Cincinnati

People needed

40

Starts

2017-11-08

Expected to finish

2018-09-06

Last updated by the study team

2019-04-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• Starting MAT with methadone or suboxone or in MAT for less than 2 weeks;

You may not qualify if…

• Does not sign the "short form" consent form

Where it is running

• University of Cincinnati Addiction Sciences Division — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.